B-FLEXION is a private, entrepreneurial investment firm that partners with capital to meet the goal of delivering value over generations, while also contributing to society. B-FLEXION has offices across Europe and in the United States.

B-FLEXION

B-FLEXION is a private, entrepreneurial investment firm that partners with sophisticated capital to meet the shared goal of delivering exceptional value over generations, while also contributing positively to society.
 
With offices across Europe and in the US, B-FLEXION invests in – and partners with – asset managers across sectors including Private Equity, Venture Capital, Infrastructure, Technology, Real Estate, Hedge Funds, Public and Private Credit, and Public Securities. It also continues to drive expansion by growing operating businesses in transformative industries. In keeping with – and building upon – its heritage, these are principally in the fields of Life Sciences, Healthcare Services and Digital Health.

We are very pleased to announce that Securis Investment Partners LLP and Twelve Capital, two independent asset management specialists in Insurance-Linked Securities (‘ILS’), plan to merge. This will create a leading founder-led business and one of the largest, most experienced ILS managers globally with $7.8bln in assets under management.

The combination of Securis Investment Partners LLP – in which B-FLEXION has been a major stakeholder since 2012 – and Twelve Capital ensures continued alignment of interests as the merger preserves its independence and client-centric approach. Securis Investment Partners LLP was founded in 2005 and remains an industry pioneer in public and private ILS, with almost two decades of experience. Twelve Capital which was founded in 2010 specialises in insurance investments and is an established market leader in catastrophe bonds with over 14 years’ experience.

With complementary investment-driven cultures and expertise, the combined business will benefit from enhanced investment capabilities and market access, alongside greater ability to invest in proprietary technology.

https://lnkd.in/gmHhKgGQ

B-Flexion is proud to be an anchor investor in Landfair Capital's first fund, its European Dislocated Opportunities fund

https://lnkd.in/e92ZJ88g

Newest member of the Gurnet Point Capital portfolio is Paratek Pharmaceuticals. More below...

BFLE

COM:BFLEXION

B-FLEXION

Filings Not Available